Researcher profile

Alok Joshi

Alok Joshi contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2020arXiv

Computational neurology: Computational modeling approaches in dementia

Dementia is a collection of symptoms associated with impaired cognition and impedes everyday normal functioning. Dementia, with Alzheimer's disease constituting its most common type, is highly complex in terms of etiology and pathophysiology. A more quantitative or computational attitude towards dementia research, or more generally in neurology, is becoming necessary - Computational Neurology. We provide a focused review of some computational approaches that have been developed and applied to the study of dementia, particularly Alzheimer's disease. Both mechanistic modeling and data-drive, including AI or machine learning, approaches are discussed. Linkage to clinical decision support systems for dementia diagnosis will also be discussed.

preprint2020arXiv

Genetic Algorithmic Parameter Optimisation of a Recurrent Spiking Neural Network Model

Neural networks are complex algorithms that loosely model the behaviour of the human brain. They play a significant role in computational neuroscience and artificial intelligence. The next generation of neural network models is based on the spike timing activity of neurons: spiking neural networks (SNNs). However, model parameters in SNNs are difficult to search and optimise. Previous studies using genetic algorithm (GA) optimisation of SNNs were focused mainly on simple, feedforward, or oscillatory networks, but not much work has been done on optimising cortex-like recurrent SNNs. In this work, we investigated the use of GAs to search for optimal parameters in recurrent SNNs to reach targeted neuronal population firing rates, e.g. as in experimental observations. We considered a cortical column based SNN comprising 1000 Izhikevich spiking neurons for computational efficiency and biologically realism. The model parameters explored were the neuronal biased input currents. First, we found for this particular SNN, the optimal parameter values for targeted population averaged firing activities, and the convergence of algorithm by ~100 generations. We then showed that the GA optimal population size was within ~16-20 while the crossover rate that returned the best fitness value was ~0.95. Overall, we have successfully demonstrated the feasibility of implementing GA to optimise model parameters in a recurrent cortical based SNN.

preprint2020arXiv

Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease

Alzheimer's disease (AD) is an age-specific neurodegenerative disease that compromises cognitive functioning and impacts the quality of life of an individual. Pathologically, AD is characterised by abnormal accumulation of beta-amyloid (A$β$) and hyperphosphorylated tau protein. Despite research advances over the last few decades, there is currently still no cure for AD. Although, medications are available to control some behavioural symptoms and slow the disease's progression, most prescribed medications are based on cholinesterase inhibitors. Over the last decade, there has been increased attention towards novel drugs, targeting alternative neurotransmitter pathways, particularly those targeting serotonergic (5-HT) system. In this review, we focused on 5-HT receptor (5-HTR) mediated signalling and drugs that target these receptors. These pathways regulate key proteins and kinases such as GSK-3 that are associated with abnormal levels of A$β$ and tau in AD. We then review computational studies related to 5-HT signalling pathways with the potential for providing deeper understanding of AD pathologies. In particular, we suggest that multiscale and multilevel modelling approaches could potentially provide new insights into AD mechanisms, and towards discovering novel 5-HTR based therapeutic targets.